Cocrystal Pharma, Inc. (COCP) - OTCQB
  • Aug. 15, 2014, 8:17 AM
    • Cocrystal Pharma (OTCQB:COCP) Q2 results: Revenues: $0; Operating Expenses: $1.4M (+34.5%); Net Income: $4.7M (change in value of derivative liabilities); EPS: $0.01; Quick Assets: $9.8M (+880.0%); Cash Burn (1H): ($3.1M) (-61.6%).
    • No financial guidance given.
    | Aug. 15, 2014, 8:17 AM
Company Description
Cocrystal is a biotechnology company which develops novel medicines for use in the treatment of human viral diseases. Cocrystal has developed proprietary structure-based drug design technology and antiviral nucleoside chemistry to create first-in-class and best-in-class antiviral drug... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States